Cite
HARVARD Citation
Fang, L. et al. (2023). Palbociclib and Michael-acceptor hybrid compounds as CDK4/6 covalent inhibitors: Improved potency, broad anticancer spectrum and overcoming drug resistance. Bioorganic & medicinal chemistry. p. . [Online].